These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 32621749

  • 21. Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism.
    Ahmad A, Sundquist K, Zöller B, Dahlbäck B, Elf J, Svensson PJ, Strandberg K, Sundquist J, Memon AA.
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):416-422. PubMed ID: 28914078
    [Abstract] [Full Text] [Related]

  • 22. Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus.
    Tydén H, Lood C, Jönsen A, Gullstrand B, Kahn R, Linge P, Kumaraswamy SB, Dahlbäck B, Bengtsson AA.
    Arthritis Res Ther; 2019 May 02; 21(1):110. PubMed ID: 31046824
    [Abstract] [Full Text] [Related]

  • 23. Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study.
    Zhang P, Gao J, Pu C, Feng G, Wang L, Huang L, Tao Q, Zhang Y.
    Lipids Health Dis; 2016 Sep 15; 15(1):158. PubMed ID: 27633510
    [Abstract] [Full Text] [Related]

  • 24. The Effect of apoM Polymorphism Associated with HDL Metabolism on Obese Korean Adults.
    Lee M, Kim JI, Choi S, Jang Y, Sorn SR.
    J Nutrigenet Nutrigenomics; 2016 Sep 15; 9(5-6):306-317. PubMed ID: 28245483
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome.
    He L, Wu P, Tan L, Le B, Du W, Shen T, Wu J, Xiang Z, Hu M.
    Lipids Health Dis; 2017 Sep 06; 16(1):167. PubMed ID: 28877724
    [Abstract] [Full Text] [Related]

  • 29. Correlation analysis between ApoM gene-promoter polymorphisms and coronary heart disease.
    Zhang Y, Huang LZ, Yang QL, Liu Y, Zhou X.
    Cardiovasc J Afr; 2016 Sep 06; 27(4):228-237. PubMed ID: 27841911
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
    Beheshti S, Madsen CM, Varbo A, Benn M, Nordestgaard BG.
    Circulation; 2018 Aug 07; 138(6):578-589. PubMed ID: 29593013
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study.
    Kamstrup PR, Nordestgaard BG.
    Lancet Diabetes Endocrinol; 2013 Nov 07; 1(3):220-7. PubMed ID: 24622370
    [Abstract] [Full Text] [Related]

  • 34. Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes.
    Safi M, Borup A, Stevns Hansen C, Rossing P, Thorsten Jensen M, Christoffersen C.
    Diabetes Res Clin Pract; 2022 Jul 07; 189():109943. PubMed ID: 35690270
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
    Karuna R, Park R, Othman A, Holleboom AG, Motazacker MM, Sutter I, Kuivenhoven JA, Rohrer L, Matile H, Hornemann T, Stoffel M, Rentsch KM, von Eckardstein A.
    Atherosclerosis; 2011 Dec 07; 219(2):855-63. PubMed ID: 21944699
    [Abstract] [Full Text] [Related]

  • 37. The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
    Park YJ, Yoo SA, Lee JH, Chung YJ, Cho CS, Kim W-.
    Clin Exp Rheumatol; 2013 Dec 07; 31(2):180-8. PubMed ID: 23190940
    [Abstract] [Full Text] [Related]

  • 38. A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese.
    Jiao GQ, Yuan ZX, Xue YS, Yang CJ, Lu CB, Lu ZQ, Xiao MD.
    Clin Biochem; 2007 Oct 07; 40(15):1108-12. PubMed ID: 17674965
    [Abstract] [Full Text] [Related]

  • 39. Plasma apoM Levels and Progression to Kidney Dysfunction in Patients With Type 1 Diabetes.
    Baker NL, Hammad SM, Hunt KJ, Semler A, Klein RL, Lopes-Virella MF.
    Diabetes; 2022 Aug 01; 71(8):1795-1799. PubMed ID: 35554520
    [Abstract] [Full Text] [Related]

  • 40. Increased apolipoprotein M induced by lack of scavenger receptor BI is not activated via HDL-mediated cholesterol uptake in hepatocytes.
    Feng YH, Zheng L, Wei J, Yu MM, Zhang J, Luo GH, Xu N.
    Lipids Health Dis; 2018 Aug 25; 17(1):200. PubMed ID: 30144814
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.